Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Piscitelli

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecular Pharmaceutics|April 10, 2023
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An <i>In Vivo</i>-<i>In Vitro</i>-<i>In Silico</i> ApproachJoseph Piscitelli, Bart Hens, Irena Tomaszewska, et al.
Clinical Pharmacology : Advances and Applications|July 2, 2020
The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination TabletRashmi Mehta, Joseph Piscitelli, Allen Wolstenholme, et al.
Clinical Drug Investigation|February 23, 2022
The Effect of Hepatic Impairment on the Pharmacokinetics of DacomitinibJoseph Piscitelli, Joseph Chen, Robert R LaBadie, et al.
Clinical Pharmacokinetics|March 12, 2026
Population Pharmacokinetic Modeling of Encorafenib in Healthy Participants and Patients with BRAF V600-Mutant Solid Tumors: A Semi-mechanistic Autoinduction ModelDerek Z Yang, Erik M Hahn, Joseph Piscitelli, et al.
Clinical Pharmacokinetics|June 23, 2025
Pharmacokinetics of Binimetinib in Participants with Hepatic ImpairmentJoseph Piscitelli, Erik Hahn, Lance Wollenberg, et al.
The AAPS Journal|July 29, 2025
Development of a Multi-Purpose Comprehensive Physiologically Based Pharmacokinetic Model for Crizotinib: An Example Application in Bioequivalence Assessment between Oral Solution and Granules in Pediatric SubjectsKazuko Sagawa, Vivek Purohit, Vu Le, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2024
Evaluation of the effect of modafinil on the pharmacokinetics of encorafenib and binimetinib in patients with BRAF V600-mutant advanced solid tumorsJoseph Piscitelli, Micaela B Reddy, Lance Wollenberg, et al.
Clinical Pharmacology and Therapeutics|November 11, 2025
An Evaluation of the Drug Interaction Potential of Encorafenib in Combination With Binimetinib Using the Inje Cocktail in Patients With CancerJoseph Piscitelli, Micaela B Reddy, Lance Wollenberg, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 12, 2023
Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in healthy adultsMarlon Liyanage, Chelsea L Blaquera, Joseph Piscitelli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2021
Optimizing Dolutegravir Initiation in Neonates Using Population Pharmacokinetic Modeling and SimulationJoseph Piscitelli, Mina Nikanjam, Brookie M Best, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular Pharmaceutics|April 10, 2023
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An <i>In Vivo</i>-<i>In Vitro</i>-<i>In Silico</i> ApproachJoseph Piscitelli, Bart Hens, Irena Tomaszewska, et al.
Clinical Pharmacology : Advances and Applications|July 2, 2020
The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination TabletRashmi Mehta, Joseph Piscitelli, Allen Wolstenholme, et al.
Clinical Drug Investigation|February 23, 2022
The Effect of Hepatic Impairment on the Pharmacokinetics of DacomitinibJoseph Piscitelli, Joseph Chen, Robert R LaBadie, et al.
Clinical Pharmacokinetics|March 12, 2026
Population Pharmacokinetic Modeling of Encorafenib in Healthy Participants and Patients with BRAF V600-Mutant Solid Tumors: A Semi-mechanistic Autoinduction ModelDerek Z Yang, Erik M Hahn, Joseph Piscitelli, et al.
Clinical Pharmacokinetics|June 23, 2025
Pharmacokinetics of Binimetinib in Participants with Hepatic ImpairmentJoseph Piscitelli, Erik Hahn, Lance Wollenberg, et al.
The AAPS Journal|July 29, 2025
Development of a Multi-Purpose Comprehensive Physiologically Based Pharmacokinetic Model for Crizotinib: An Example Application in Bioequivalence Assessment between Oral Solution and Granules in Pediatric SubjectsKazuko Sagawa, Vivek Purohit, Vu Le, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2024
Evaluation of the effect of modafinil on the pharmacokinetics of encorafenib and binimetinib in patients with BRAF V600-mutant advanced solid tumorsJoseph Piscitelli, Micaela B Reddy, Lance Wollenberg, et al.
Clinical Pharmacology and Therapeutics|November 11, 2025
An Evaluation of the Drug Interaction Potential of Encorafenib in Combination With Binimetinib Using the Inje Cocktail in Patients With CancerJoseph Piscitelli, Micaela B Reddy, Lance Wollenberg, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 12, 2023
Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in healthy adultsMarlon Liyanage, Chelsea L Blaquera, Joseph Piscitelli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2021
Optimizing Dolutegravir Initiation in Neonates Using Population Pharmacokinetic Modeling and SimulationJoseph Piscitelli, Mina Nikanjam, Brookie M Best, et al.
Pageof 2